US 10138291
Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof
granted A61KA61K38/00A61K38/36
Quick answer
US patent 10138291 (Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof) held by BIOVERATIV THERAPEUTICS INC. expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K38/00, A61K38/36, A61K38/37, A61K47/55